首页> Archives of pathology & laboratory medicine> Molecular Profiling of Syringocystadenocarcinoma Papilliferum Reveals RAS-Activating Mutations.

Molecular Profiling of Syringocystadenocarcinoma Papilliferum Reveals RAS-Activating Mutations.

导出原文传递

翻译打印收藏纠错

第一作者： Kristine M,Cornejo

第一单位： From the Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts (Cornejo, Nazarian).

作者： Kristine M,Cornejo ^[1] ; Lloyd,Hutchinson ^[2] ; Patrick,O'Donnell ^[2] ; Xiuling,Meng ^[2] ; Keith,Tomaszewicz ^[2] ; Sara C,Shalin ^[3] ; David S,Cassarino ^[4] ; May P,Chan ^[5] ; Timothy R,Quinn ^[6] ; Paul B,Googe ^[7] ; Rosalynn M,Nazarian ^[1]

作者单位： From the Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts (Cornejo, Nazarian). ^[1] Department of Pathology, University of Massachusetts Memorial Medical Center, Worcester, Massachusetts (Hutchinson, O'Donnell, Meng, Tomaszewicz). ^[2] Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (Shalin). ^[3] Southern California Permanente Medical Group, Sunset Medical Center, Department of Pathology, Los Angeles, California (Cassarino). ^[4] Department of Pathology, University of Michigan Health System, Ann Arbor, Michigan (Chan). ^[5] Massachusetts General Physicians Organization Dermatopathology Associates, Newton, Massachusetts (Quinn). ^[6] the Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (Googe). ^[7]